Novo Nordisk A/S

Novo Nordisk A/S is a Danish multinational pharmaceutical company specializing in diabetes care, headquartered in Bagsværd, Denmark. It was formed in 1989 through the merger of two Danish companies: Nordisk Insulinlaboratorium and Novo Terapeutisk Laboratorium. The company is controlled by its majority shareholder, Novo Holdings A/S, which holds approximately 28% of its shares and a majority (77%) of its voting shares. Novo Nordisk manufactures and markets pharmaceutical products and services, specifically diabetes care medications and devices, and employs more than 77,000 people globally, marketing its products in 170 countries. The company's logo features the Apis bull, an ancient Egyptian symbol. In 2024, Novo Nordisk's revenue was US$33.724 billion, and it was ranked as the most valuable company in Europe. The company is also known for its commitment to sustainability, being the first pharmaceutical company to use 100% renewable power in all its global production facilities. (en.wikipedia.org, novonordisk.com)